SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 917.16 |
| Enterprise Value ($M) | 1,062.73 |
| Book Value ($M) | 268.24 |
| Book Value / Share | 0.42 |
| Price / Book | 3.42 |
| NCAV ($M) | 201.56 |
| NCAV / Share | 0.32 |
| Price / NCAV | 4.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.97 |
| Current Ratio | 7.87 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 495.77 |
| Assets | 562.45 |
| Liabilities | 294.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 76.99 |
| Operating Income | -173.73 |
| Net Income | -174.57 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -218.62 |
| Cash from Investing | -106.00 |
| Cash from Financing | 334.37 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ra Capital Management, L.p. | 9.90 | 1.06 | |
| 13G | Deep Track Capital, LP | 5.50 | 362.04 | |
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,915,337 | 12,272,095 | 40.05 | |
| 5,878,503 | 19,052,909 | 30.85 | |
| 3,433,299 | 8,169,783 | 42.02 | |
| 2,714,679 | 7,616,381 | 35.64 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FDMT – 4D Molecular Therapeutics, Inc. | FGEN – FibroGen, Inc. |
| GBIO – Generation Bio Co. | GILD – Gilead Sciences, Inc. |
| GLUE – Monte Rosa Therapeutics, Inc. |